文献速递免疫规划妇幼与学校卫生

孕妇接种风疹疫苗的安全性概况:对免疫接种后妊娠相关不良事件的系统综述,包括先天性风疹综合征及胎儿或婴儿先天性风疹感染

Safety profile of rubella vaccine administered to pregnant women: A systematic review of pregnancy related adverse events following immunisation, including congenital rubella syndrome and congenital rubella infection in the foetus or infant.
PubMed 文献 · Vaccine · 2019-12-12

该系统综述与荟萃分析评估了妊娠期或妊娠前不久接种风疹单价或联合疫苗与胎儿潜在危害的关联。未发现疫苗相关先天性风疹综合征(CRS)病例,但可发生经胎盘疫苗病毒感染;基于风疹易感孕妇队列估算最大理论风险为1008名接种者中1例CRS(观察0%,95%CI上限0.099%)。结论认为无证据表明含风疹疫苗导致CRS,风险获益明确支持接种,意外接种不是终止妊娠的指征。

要点

  • 未发现疫苗相关先天性风疹综合征病例。
  • 风疹易感孕妇接种后CRS最大理论风险为1008名中1例(观察0%,95%CI上限0.099%)。
  • 可发生新生儿无症状风疹疫苗病毒感染,固定效应合并风险估计为1.74%(95%CI 1.21-2.28)。

核心结论

  • 无证据表明含风疹疫苗导致先天性风疹综合征,但可发生经胎盘疫苗病毒感染。
  • 风疹可通过接种有效预防,风险获益明确支持接种。
  • 数据证实既往建议:妊娠期意外接种不是终止妊娠的指征。

研究设计与样本

  • 系统综述与荟萃分析,采用固定效应法和模拟。
  • 纳入4项意外接种与未接种女性的队列研究、15个接种时风疹易感孕妇队列、9项无易感性信息的队列研究和病例系列。

主要发现

  • 未发现疫苗相关先天性风疹综合征病例。
  • 有未接种对照组的队列研究数量与规模有限,仅能排除每1000名接种女性中6例或以上CRS的理论额外风险(观察0%,95%CI上限0.6%)。
  • 基于风疹易感孕妇接种队列,估算最大理论风险为1008名接种女性中1例CRS(观察0%,95%CI上限0.099%)。
  • 新生儿无症状风疹疫苗病毒感染固定效应合并风险估计为1.74%(95%CI 1.21-2.28)。

临床怎么用

  • 原文结论指出,妊娠期意外接种不是终止妊娠的指征。

局限性

  • 有未接种对照组的队列研究数量与规模有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Data on the safety of inadvertent rubella vaccination in pregnancy is important for rubella vaccination programs aimed at preventing congenital rubella syndrome. METHODS: The association between monovalent rubella or combination vaccinations in or shortly before pregnancy and potential harm to the foetus was examined by conducting a systematic review and meta-analysis using fixed effect methods and simulation. RESULTS: Four cohort studies of inadvertently vaccinated and unvaccinated women were found, 15 cohorts of pregnant women who were rubella susceptible at time of inadvertent vaccination and 9 cohort studies with no information on susceptibility and case series. No case of vaccine associated congenital rubella syndrome (CRS) was identified. Cohort studies with an unvaccinated comparison group were limited in number and size, and based on these only a theoretical additional risk of 6 or more cases of CRS per 1000 vaccinated women (0% observed, upper 95% CI 0.6%) could be excluded. Based on cohorts of vaccinated rubella susceptible pregnant women a maximum theoretical risk of 1 CRS case in 1008 vaccinated women (0% observed, upper 95% CI 0.099%) was estimated. Asymptomatic rubella vaccine virus infection of the neonate was also noted (fixed effects estimate of risk overall 1.74%, 95% CI 1.21, 2.28). CONCLUSION: There is no evidence that CRS is caused by rubella-containing vaccines but transplacental vaccine virus infection can occur. CRS is effectively prevented by vaccination, thus the risk/benefit balance is unequivocally in favour of vaccination. The data confirm previous recommendations that inadvertent vaccination during pregnancy is not an indication for termination of pregnancy.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Mangtani P, Evans SJW, Lange B, et al. Safety profile of rubella vaccine administered to pregnant women: A systematic review of pregnancy related adverse events following immunisation, including congenital rubella syndrome and congenital rubella infection in the foetus or infant. Vaccine. 2019. PMID: 31839467. doi:10.1016/j.vaccine.2019.11.070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。